All

FDA Approves Long-Acting Injectable Buprenorphine for Opioid Use Disorder

The injectable is approved in both weekly and monthly formulations at varying doses, including lower doses that may be appropriate for those who do not tolerate higher doses.

All

Variant Cells Discovered in Lungs of IPF Patients

Stem cell cloning experts are reporting their findings of variant cells in the lungs of patients with idiopathic pulmonary fibrosis, which likely represent key targets in any future therapy for the condition.

All

FDA Approves First RSV Vaccine

In clinical trials, the vaccine significantly reduced the risk of developing RSV-associated lower respiratory tract disease by 82.6% and reduced the risk of developing severe RSV-associated lower respiratory tract disease by 94.1% in adults age 60 and older.

Disorders & Diseases

FDA Clears Hologic’s Test to Detect SARS-CoV-2, Influenza A/B, and RSV

According to Hologic, the test will be a critical tool this upcoming season to help clinicians determine which respiratory virus or coinfection patients have to better inform the best course of treatment.

Pediatrics

FDA Clears Wireless Monitoring System for Neonates and Infants

The wearable vital-sign sensors, previously cleared for adults, are now being tested at Montreal Children's Hospital with a vision to create a wireless NICU.

Products & Treatment

FDA Blocks 6,500 Flavored E-cigarette Products from 10 Companies

The companies' premarket tobacco product applications, which were for a variety of flavored e-cigarette products, did not provide sufficient evidence to show that permitting the marketing of these products would be appropriate for the protection of the public health, according to the FDA.

Smoking, Vaping & E-Cigarettes

Prediagnosis Smoking Cessation Linked to Higher Lung Cancer Survival Rates

Compared to those who never smoked and were being treated for non-small cell lung cancer, current smokers had 68% higher mortality while former smokers had 26% higher mortality.

Critical Care

Severe COVID-19 Patients At 16 Times Greater Risk of Ventricular Tachycardia

COVID-19 patients requiring mechanical ventilation are at a significantly greater risk of developing ventricular tachycardia within six months compared to their peers without severe infection, according to research presented at EHRA 2023.

Infectious Diseases

Biological Mechanisms of Long COVID Neurological Symptoms Identified

Twelve people with persistent neurological symptoms after SARS-CoV-2 infection were intensely studied at the National Institutes of Health and were found to have differences in their immune cell profiles and autonomic dysfunction.